Tech Company Financing Transactions
The Vaccine Company Funding Round
The Vaccine Company, operating out of South San Francisco, secured $6.2 million from DPEC Partners and private investors.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$6,200,100
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
601 Gateway Blvd. 450
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
The Vaccine Company is a biotechnology company that is developing novel therapeutic vaccines for the treatment of leukemias and other cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Thayer
Chief Medical Officer
Craig Rosenfeld
Browse more venture capital transactions:
Prev: 6/30/2006: Liquidia Technologies venture capital transaction
Next: 6/30/2006: Serene Medical venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs